Tenon Medical, Inc. financial data

Symbol
TNON, TNONW on Nasdaq
Location
104 Cooper Ct., Los Gatos, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 421 % +165%
Quick Ratio 25.6 % +34.1%
Debt-to-equity 56.7 % -78%
Return On Equity -167 % +76.6%
Return On Assets -107 % +46.7%
Operating Margin -438 % -6.39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.88M shares +125%
Common Stock, Shares, Outstanding 7.59M shares +101%
Common Stock, Value, Issued 8K USD +100%
Weighted Average Number of Shares Outstanding, Basic 7.59K shares +1519%
Weighted Average Number of Shares Outstanding, Diluted 7.59K shares +1519%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.95M USD -12.6%
Cost of Revenue 1.61M USD +20.2%
Research and Development Expense 2.42M USD -13.7%
Selling and Marketing Expense 5.05M USD -11.4%
General and Administrative Expense 6.8M USD -8.52%
Operating Income (Loss) -12.9M USD +7.02%
Nonoperating Income (Expense) 266K USD +817%
Net Income (Loss) Attributable to Parent -12.7M USD +8.74%
Earnings Per Share, Basic 5 USD/shares +95.6%
Earnings Per Share, Diluted 5 USD/shares +95.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.85M USD +299%
Accounts Receivable, after Allowance for Credit Loss, Current 770K USD +13.4%
Inventory, Net 688K USD +13%
Assets, Current 9.88M USD +142%
Property, Plant and Equipment, Net 842K USD -6.86%
Operating Lease, Right-of-Use Asset 268K USD -49%
Assets 11.1M USD +85%
Accounts Payable, Current 894K USD -19.5%
Accrued Liabilities, Current 1.11M USD +18.9%
Liabilities, Current 2.56M USD -24.7%
Operating Lease, Liability, Noncurrent 65K USD -81.9%
Liabilities 4.4M USD -14.9%
Retained Earnings (Accumulated Deficit) -75.1M USD -20.3%
Stockholders' Equity Attributable to Parent 6.71M USD +707%
Liabilities and Equity 11.1M USD +85%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.48M USD -6.2%
Net Cash Provided by (Used in) Financing Activities 6.26M USD +43.2%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 7.59M shares +101%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.78M USD +92.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.85M USD +299%
Operating Lease, Liability 290K USD -48.3%
Depreciation 312K USD +1.96%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.7M USD +8.26%
Lessee, Operating Lease, Liability, to be Paid 302K USD -50.3%
Property, Plant and Equipment, Gross 1.6M USD +18.5%
Operating Lease, Liability, Current 290K USD +7.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 144K USD -53.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12K USD -74.5%
Operating Lease, Payments 76K USD +2.7%
Additional Paid in Capital 78.1M USD +30.1%
Share-based Payment Arrangement, Expense 3.08M USD -40.2%